STOCK TITAN
  1. Home
  2. Sec-filings
  3. RBOT
  4. [8-K] Vicarious Surgical Inc. Reports Material Event

CFO Sarah Romano to resign from Vicarious Surgical Inc. (RBOT) in July 2026

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

Vicarious Surgical Inc. reported that Chief Financial Officer Sarah Romano has resigned. She notified the Board on June 24, 2026, with her resignation effective July 22, 2026, or a later mutually agreed date. The company states her resignation is not due to any disagreement regarding operations, policies, or practices. Ms. Romano will continue to serve as CFO until her resignation becomes effective.

Positive

  • None.

Negative

  • None.

Insights

CFO resignation disclosed without reported disputes or immediate successor details.

Vicarious Surgical Inc. reports that Chief Financial Officer Sarah Romano has resigned, effective July 22, 2026, or a later mutually agreed date. The company explicitly notes that her decision is not the result of any disagreement over operations, policies, or practices.

Management transitions at the CFO level can matter for financial leadership and reporting continuity, but this disclosure is narrowly focused on her departure and timing. Future updates in company communications or later filings would clarify succession plans and any longer-term implications for the finance function.

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers Governance
Key personnel changes including departures, elections, or appointments of directors and executive officers.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
Emerging growth company regulatory
"405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company"
An emerging growth company is a recently public or smaller public firm that qualifies for temporary, lighter regulatory and disclosure rules to reduce the cost and effort of being public. For investors, it means the company may provide less historical financial detail and face fewer reporting requirements than larger firms, so it can grow more quickly but also carries higher uncertainty—like buying a promising early-stage product with fewer user reviews.
Item 5.02 regulatory
"Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers."
Chief Financial Officer financial
"Resignation of Sarah Romano, Chief Financial Officer On June 24, 2026, Sarah Romano notified the Board of Directors of her resignation as Chief Financial Officer"
A Chief Financial Officer (CFO) is the person in charge of a company's money and financial planning. They decide how to spend, save, and invest funds to help the company grow and stay stable. Their role is important because good financial decisions keep the company healthy and successful.
Inline XBRL technical
"Cover Page Interactive Data File (embedded within the Inline XBRL document)"
Inline XBRL is a file format for financial filings that embeds machine-readable data tags directly inside the human-readable report, so the same document can be read by people and parsed by software. For investors it makes extracting, comparing and verifying financial numbers faster and more reliable—like a grocery list where each item also has a barcode—reducing manual errors and speeding up analysis.

FAQ

Why did Vicarious Surgical Inc. (RBOT) announce a CFO change?
Vicarious Surgical Inc. announced that Chief Financial Officer Sarah Romano has resigned. According to the company, her resignation is not due to any disagreement regarding operations, policies, or practices, and she will remain in the role until her effective resignation date.

When will Vicarious Surgical’s (RBOT) CFO Sarah Romano step down?
Sarah Romano’s resignation as Chief Financial Officer is effective July 22, 2026, or a later date mutually agreed by her and Vicarious Surgical Inc. She will continue serving as CFO and performing her duties through the effective resignation date mentioned in the company’s disclosure.

What SEC item did Vicarious Surgical (RBOT) use to disclose the CFO resignation?
The company disclosed the CFO resignation under Item 5.02, which covers departures and appointments of directors and certain officers, as well as compensatory arrangements. This item is typically used to inform investors of key leadership or governance changes at a public company.

Who signed the Vicarious Surgical (RBOT) report announcing the CFO resignation?
The report announcing Chief Financial Officer Sarah Romano’s resignation was signed on behalf of Vicarious Surgical Inc. by Chief Executive Officer Stephen From. His signature appears in the closing section, indicating company authorization for the submitted current report.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Understanding 8-K Material Events →
false 0001812173 0001812173 2026-06-24 2026-06-24 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of the

Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): June 24, 2026

 

VICARIOUS SURGICAL INC.

(Exact name of registrant as specified in its charter)

 

Delaware   001-39384   87-2678169
(State or other jurisdiction of incorporation)   (Commission File Number)   (IRS Employer
Identification No.)

 

78 Fourth Avenue    
Waltham, Massachusetts   02451
(Address of principal executive offices)   (Zip Code)

 

Registrant’s telephone number, including area code: (617) 868-1700

 

N/A

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act: None.

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ☒

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 

Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

 

Resignation of Sarah Romano, Chief Financial Officer

 

On June 24, 2026, Sarah Romano notified the Board of Directors of her resignation as Chief Financial Officer of the Company, effective July 22, 2026, or such later date as may be mutually agreed upon by the Company and Ms. Romano. Ms. Romano's resignation was not the result of any disagreement with the Company on any matter relating to the Company's operations, policies or practices. Ms. Romano will continue to serve as Chief Financial Officer through the effective date of her resignation.

 

Item 9.01. Financial Statements and Exhibits.

 

(d) Exhibits.

 

Exhibit Number   Exhibit Description
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

1

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  VICARIOUS SURGICAL INC.
     
  By: /s/Stephen From
    Stephen From
    Chief Executive Officer

 

Date: June 24, 2026

 

 

2

 

Source: View Original Filing on SEC EDGAR

Filing Exhibits & Attachments

3 documents

Other Documents